Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$525M |
| 2 |
Accenture
ACN
|
+$382M |
| 3 |
AGN
Allergan plc
AGN
|
+$348M |
| 4 |
Broadcom
AVGO
|
+$299M |
| 5 |
Chubb
CB
|
+$284M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$87.2M |
| 2 |
Chevron
CVX
|
+$55.9M |
| 3 |
Alcoa
AA
|
+$53.2M |
| 4 |
Yum! Brands
YUM
|
+$47M |
| 5 |
AT&T
T
|
+$39.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.34% |
| 2 | Technology | 13.95% |
| 3 | Healthcare | 12.6% |
| 4 | Industrials | 9.35% |
| 5 | Communication Services | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Karyopharm Therapeutics
KPTI
$44.6M
| $70K | ﹤0.01% |
498
+201
| +68% | +$27.2K |
|
2752
LSI Industries
LYTS
$886M
| $70K | ﹤0.01% |
7,131
+3,286
| +85% | +$32.4K |
|
2753
MannKind Corp
MNKD
$1.17B
| $70K | ﹤0.01% |
21,636
+6,169
| +40% | +$17.8K |
|
2754
Reading International Class A
RDI
$32.7M
| $70K | ﹤0.01% |
4,196
+1,420
| +51% | +$20.8K |
|
2755
Rapid7
RPD
$680M
| $70K | ﹤0.01% |
5,745
+2,758
| +92% | +$37.3K |
|
|
NVTA
2756
DELISTED
Invitae Corporation
NVTA
| $70K | ﹤0.01% |
8,894
+4,774
| +116% | +$35.7K |
|
|
GCAP
2757
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $70K | ﹤0.01% |
10,669
+5,266
| +97% | +$31.7K |
|
|
CHFN
2758
DELISTED
Charter Financial Corp
CHFN
| $70K | ﹤0.01% |
4,200
+646
| +18% | +$9.07K |
|
|
AVXS
2759
DELISTED
AveXis, Inc. Common Stock
AVXS
| $70K | ﹤0.01% |
1,463
+624
| +74% | +$33.3K |
|
|
STS
2760
DELISTED
Supreme Industries Inc Class A
STS
| $70K | ﹤0.01% |
4,471
+2,070
| +86% | +$31.1K |
|
|
WMAR
2761
DELISTED
West Marine Inc
WMAR
| $70K | ﹤0.01% |
6,630
+3,127
| +89% | +$28.7K |
|
2762
Adecoagro
AGRO
$1.37B
| $69K | ﹤0.01% |
+6,672
| New | +$71.8K |
|
2763
Altimmune
ALT
$583M
| $69K | ﹤0.01% |
71
+32
| +82% | +$28.7K |
|
2764
Costamare
CMRE
$1.87B
| $69K | ﹤0.01% |
+12,270
| New | +$81.4K |
|
2765
Ducommun
DCO
$2.76B
| $69K | ﹤0.01% |
2,645
+853
| +48% | +$20.8K |
|
2766
Lesaka Technologies
LSAK
$401M
| $69K | ﹤0.01% |
+6,000
| New | +$65.9K |
|
2767
Minerva Neurosciences
NERV
$185M
| $69K | ﹤0.01% |
729
+363
| +99% | +$37.1K |
|
2768
Plug Power
PLUG
$2.9B
| $69K | ﹤0.01% |
57,034
+23,675
| +71% | +$34.8K |
|
|
LGTY
2769
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $69K | ﹤0.01% |
6,632
+2,588
| +64% | +$27.7K |
|
2770
Evolution Petroleum
EPM
$129M
| $68K | ﹤0.01% |
6,889
+3,256
| +90% | +$27.3K |
|
2771
Utah Medical Products
UTMD
$232M
| $68K | ﹤0.01% |
951
+353
| +59% | +$22.9K |
|
2772
Wave Life Sciences
WVE
$1.13B
| $68K | ﹤0.01% |
+2,532
| New | +$82.4K |
|
|
BLCM
2773
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $68K | ﹤0.01% |
493
+207
| +72% | +$36.7K |
|
|
OHAI
2774
DELISTED
OHA Investment Corporation
OHAI
| $68K | ﹤0.01% |
39,283
| – | – |
|
|
LJPC
2775
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $68K | ﹤0.01% |
3,994
+1,953
| +96% | +$37.4K |
|
Similar funds
Legal & General Group's Q4 2016 Portfolio in Review
As of Q4 2016, Legal & General Group held 3,339 positions worth $107B, up 8.6% from $98.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Legal & General Group deployed $5.14B of net new capital in Q4 2016, opening 462 new positions and adding to 2,302 existing holdings. Its largest new stake was Medtronic: 6,678,082 shares worth $476M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Chevron, an estimated $55.9M trimmed.
- Legal & General Group's largest Q4 2016 buy was Medtronic: 6,678,082 shares worth $476M.
- Legal & General Group added most to Microsoft in Q4 2016, an estimated $55.7M increase.
- Legal & General Group's biggest Q4 2016 reduction was Chevron, cutting an estimated $55.9M.
- Legal & General Group fully exited LinkedIn Corporation in Q4 2016, selling an estimated $87.2M.
- Legal & General Group's ten largest holdings make up 15% of its $107B portfolio in Q4 2016.
- Legal & General Group opened 462 new positions and closed 50 in Q4 2016.
- Legal & General Group's portfolio value rose 8.6% quarter-over-quarter to $107B.
Based on Legal & General Group's 13F filing for Q4 2016, filed 13 Feb 2017.